Concerning the role of the GH/IGF1 system in the pathogenesis of NAFLD/NASH, it has been reported that decrease in the levels of system components is closely associated with the progression of NAFLD [33]. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.